2m 2m 2m 2m 2m 2m 2m
Amgen (AMGN)
NASDAQ
$472.52+$4.41 (+0.94%)
Price as of Nov 12, 2026 8:20 AM EST- $253.2BMarket Cap
- 43.06%1-Year Change
- Drug Manufacturers - GeneralIndustry
Amgen (AMGN)
$472.52+$4.41 (+0.94%)
Earnings Score
Valuation | AMGN | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 1 | ||
Growth | 0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | AMGN | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 0.23% | ||
12-Month Momentum | 25.36% | ||
3-Month Risk Adjusted Momentum | 1.57% | ||
12-Month Risk Adjusted Momentum | 92.53% |
True Yield
Valuation | AMGN | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | 2.15% | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | 1.73% |
Financial Health Score
Valuation | AMGN | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 8 |